1. Elanco to buy Bayer’s animal health business for $7.6 billion — Vanda Pharmaceuticals “perplexed” by FDA rejection of jet lag drug — AstraZeneca's diabetes drug Farxiga helps patients with heart disease and without diabetes in landmark trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Amgen buy otezla

Discussion in 'Celgene' started by anonymous, Jul 18, 2019 at 3:14 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    then fire you all
     
  2. anonymous

    anonymous Guest

    Will they have enough resources to handle Otezla??
     
  3. anonymous

    anonymous Guest

    Nah, my guess is Gilead. And they will need a salesforce:D
     
  4. anonymous

    anonymous Guest

    Gilead will buy, they got a ton of cash
     
  5. anonymous

    anonymous Guest

    How is that possible if their jak inhibitor is an oral and in phase 3’s for PsA?
     
  6. anonymous

    anonymous Guest

    Their in phase 3 for RA Not PSA, that is still Far away. Maybe they could abandon that indication LOL